Evidence map›Paper›PMID 37073838›Full record

Trial reportZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics2023

[Clinical efficacy of mild therapeutic hypothermia with different rewarming time on neonatal hypoxic-ischemic encephalopathy: a prospective randomized controlled study].

Yu-Xin Lin, Xiao Feng, Yi-Dan Zhang, Wan-Rong Hong, Hong-Ying Zhao

Open access · greenAbstract readRandomized Controlled TrialEnglish Abstract
In one paragraph

Trial report in Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yu-Xin LinDepartment of Pediatrics, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361004, China.
Xiao FengDepartment of Pediatrics, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361004, China.
Yi-Dan ZhangDepartment of Pediatrics, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361004, China.
Wan-Rong HongDepartment of Pediatrics, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361004, China.
Hong-Ying ZhaoDepartment of Pediatrics, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361004, China.
Zhongshan Hospital of Xiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the clinical efficacy of mild therapeutic hypothermia (MTH) with different rewarming time on neonatal hypoxic-ischemic encephalopathy (HIE).

methodsA prospective study was performed on 101 neonates with HIE who were born and received MTH in Zhongshan Hospital, Xiamen University, from January 2018 to January 2022. These neonates were randomly divided into two groups: MTH1 group (

resultsThere were no significant differences between the MTH1 and MTH2 groups in gestational age, 5-minute Apgar score, and proportion of neonates with moderate/severe HIE (

conclusionsRewarming for 10 hours has a better short-term clinical efficacy than rewarming for 25 hours. Prolonging rewarming time has limited clinical benefits on neonates with moderate/severe HIE and is not conducive to the occurrence of normal SWC, and therefore, it is not recommended as a routine treatment method.

Indexed as

Hypothermia, InducedHypoxia-Ischemia, BrainChildChild, PreschoolElectroencephalographyHumansInfantInfant, NewbornProspective StudiesRewarmingTreatment OutcomeClinical efficacyHypoxic-ischemic encephalopathyMild therapeutic hypothermiaNeonateRewarming

Identifiers

PMID37073838
PMCPMC10120331
OpenAlexW4366351501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.